26419 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
from the standards in Section 3 of this 
regulation’’). These revisions do not change how the regulation operates and solely serves as an update to clarify that the exemption only applies to emissions standards in each regulation, as recordkeeping requirements are still explicitly required. 
III. Incorporation by Reference 
In this document, EPA is proposing to 
include in a final EPA rule regulatory 
text that includes incorporation by reference. In accordance with requirements of 1 CFR 51.5, EPA is proposing to incorporate by reference 
Louisville Metro Air Pollution Control District Regulation 6.31, Standard of Performance for Existing Miscellaneous Metal Parts and Products Surface Coating Operations, Version 7, and Regulation 7.59, Standard of Performance for New Miscellaneous Metal Parts and Products Surface Coating Operations, Version 7, state effective June 19, 2019. EPA has made, and will continue to make, these materials generally available through www.regulations.gov and at the EPA 
Region 4 office (please contact the person identified in the ‘‘For Further Information Contact’’ section of this preamble for more information). 
IV. Proposed Action 
EPA is proposing to approve the 
change to Regulation 6.31, Standard of 
Performance for Existing Miscellaneous Metal Parts and Products Surface Coating Operations, and Regulation 7.59, Standard of Performance for New 
Miscellaneous Metal Parts and Products Surface Coating Operations, of the Jefferson County portion of the Kentucky SIP as submitted on September 5, 2019. This change clarifies the existing regulations’ applicability and is consistent with the CAA. 
V. Statutory and Executive Order 
Reviews 
Under the CAA, the Administrator is 
required to approve a SIP submission that complies with the provisions of the Act and applicable Federal regulations. See 42 U.S.C. 7410(k); 40 CFR 52.02(a). 
Thus, in reviewing SIP submissions, EPA’s role is to approve state choices, provided that they meet the criteria of the CAA. This action merely proposes to approve state law as meeting Federal requirements and does not impose additional requirements beyond those imposed by state law. For that reason, this proposed action: 
•Is not a significant regulatory action 
subject to review by the Office of Management and Budget under Executive Orders 12866 (58 FR 51735, October 4, 1993) and 13563 (76 FR 3821, January 21, 2011); 
•Is not an Executive Order 13771 (82 
FR 9339, February 2, 2017) regulatory action because SIP approvals are exempted under Executive Order 12866; 
•Does not impose an information 
collection burden under the provisions of the Paperwork Reduction Act (44 U.S.C. 3501 et seq.); 
•Is certified as not having a 
significant economic impact on a substantial number of small entities under the Regulatory Flexibility Act (5 U.S.C. 601 et seq.); 
•Does not contain any unfunded 
mandate or significantly or uniquely affect small governments, as described in the Unfunded Mandates Reform Act of 1955 (Pub. L. 104–4); 
•Does not have Federalism 
implications as specified in the Executive Order 13132 (64 FR 43255, August 10, 1999); 
•Is not an economically significant 
regulatory action based on health or safety risks subject to Executive Order 13045 (62 FR 19885, April 23, 1997); 
•Is not a significant regulatory action 
subject to Executive Order 13211 (66 FR 28355, May 22, 2001); 
•Is not subject to requirements of 
Section 12(d) of the national Technology Transfer and Advancement Act of 1995 (15 U.S.C. 272 note) because application of those requirements would be inconsistent with the CAA; and 
•Does not provide EPA with the 
discretionary authority to address, as appropriate, disproportionate human health or environmental effects, using practicable and legally permissible methods, under Executive Order 12898 (59 FR 7629, February 16, 1994). The SIP is not approved to apply on any Indian reservation land or any other area where EPA or an Indian tribe has demonstrated that a tribe has jurisdiction. In those areas of Indian country, the rules do not have tribal implications as specified by Executive Order 13175 (65 FR 67249, November 9, 2000), nor will it impose substantial direct costs on tribal governments or preempt tribal law. 
List of Subjects in 40 CFR Part 52 
Environmental protection, Air 
pollution control, Incorporation by 
reference, Intergovernmental relations, Ozone, Particulate matter, Reporting and recordkeeping requirements, Volatile organic compounds. 
Authority: 42 U.S.C. 7401 et seq. 
Mary Walker, 
Regional Administrator, Region 4. 
[FR Doc. 2020–08905 Filed 5–1–20; 8:45 am] 
BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION 
AGENCY 
40 CFR Part 721 
[EPA–HQ–OPPT–2019–0596; FRL–10007– 
65] 
RIN 2070–AB27 
Significant New Use Rules on Certain 
Chemical Substances (20–1.5e) 
AGENCY : Environmental Protection 
Agency (EPA). 
ACTION : Proposed rule. 
SUMMARY : EPA is proposing significant 
new use rules (SNURs) under the Toxic Substances Control Act (TSCA) for chemical substances that were the subject of premanufacture notices (PMNs) and are subject to Orders issued by EPA pursuant TSCA. The SNURs require persons who intend to manufacture (defined by statute to include import) or process any of these chemical substances for an activity that is proposed as a significant new use by this rule to notify EPA at least 90 days before commencing that activity. The required notification initiates EPA’s evaluation of the use, under the conditions of use for that chemical substance, within the applicable review period. Persons may not commence manufacture or processing for the significant new use until EPA has conducted a review of the notice, made an appropriate determination on the notice, and has taken such actions as are required by that determination. 
DATES : Comments must be received on 
or before June 3, 2020. 
ADDRESSES : Submit your comments, 
identified by docket identification (ID) number EPA–HQ–OPPT–2019–0596, by one of the following methods: 
•Federal eRulemaking Portal: http:// 
www.regulations.gov. Follow the online 
instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. 
•Mail: Document Control Office 
(7407M), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania 
Ave. NW, Washington, DC 20460–0001. 
•Hand Delivery: To make special 
arrangements for hand delivery or delivery of boxed information, please follow the instructions at http://www.epa.gov/dockets/contacts.html. 
Additional instructions on 
commenting or visiting the docket, along with more information about dockets generally, is available at http:// 
www.epa.gov/dockets. 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00051 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26420 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
FOR FURTHER INFORMATION CONTACT : For 
technical information contact: Kenneth 
Moss, Chemical Control Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–9232; email address: moss.kenneth@epa.gov. 
For general information contact: The 
TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@epa.gov. 
SUPPLEMENTARY INFORMATION : 
I. General Information 
A. Does this action apply to me? 
You may be potentially affected by 
this action if you manufacture, process, 
or use the chemical substances contained in this proposed rule. The following list of North American Industrial Classification System (NAICS) codes is not intended to be exhaustive, but rather provides a guide to help readers determine whether this document applies to them. Potentially affected entities may include: 
•Manufacturers or processors of one 
or more subject chemical substances (NAICS codes 325 and 324110), e.g., chemical manufacturing and petroleum refineries. 
This action may also affect certain 
entities through pre-existing import certification and export notification rules under TSCA. Chemical importers are subject to the TSCA section 13 (15 U.S.C. 2612) import certification requirements promulgated at 19 CFR 12.118 through 12.127 and 19 CFR 127.28. Chemical importers must certify that the shipment of the chemical substance complies with all applicable rules and Orders under TSCA. Importers of chemicals subject to final SNURs must certify compliance with the SNUR requirements. The EPA policy in support of import certification appears at 40 CFR part 707, subpart B. In addition, any persons who export or intend to export a chemical substance that is the subject of this proposed rule on or after June 3, 2020 are subject to the export notification provisions of TSCA section 12(b) (15 U.S.C. 2611(b)) (see 40 CFR 721.20), and must comply with the export notification requirements in 40 CFR part 707, subpart D. 
B. What should I consider as I prepare 
my comments for EPA? 
1. Submitting CBI. Do not submit this 
information to EPA through regulations.gov or email. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD–ROM that you mail to EPA, mark the outside of the disk or CD–ROM as CBI and then identify electronically within the disk or CD–ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 
2. Tips for preparing your comments. 
When preparing and submitting your comments, see the commenting tips at http://www.epa.gov/dockets/ comments.html. 
II. Background A. What action is the agency taking? 
EPA is proposing these SNURs under 
TSCA section 5(a)(2) for chemical 
substances that were the subject of PMNs. These proposed SNURs would require persons to notify EPA at least 90 days before commencing the manufacture or processing of a chemical substance for any activity proposed as a significant new use. Receipt of such notices would allow EPA to assess risks and, if appropriate, to regulate the significant new use before it may occur. Additional background regarding SNURs is more fully set out in the preamble to EPA’s first direct final SNUR published in the Federal Register issue of April 24, 1990 (55 FR 17376). Consult that preamble for further general information on the objectives, rationale, and procedures for SNURs and on the basis for significant new use designations, including provisions for developing test data. 
B. What is the Agency’s authority for 
taking this action? 
TSCA section 5(a)(2) (15 U.S.C. 
2604(a)(2)) authorizes EPA to determine that a use of a chemical substance is a ‘‘significant new use.’’ EPA must make this determination by rule after considering all relevant factors, including the four TSCA section 5(a)(2) factors listed in Unit III. Once EPA determines that a use of a chemical substance is a significant new use, TSCA section 5(a)(1)(B) requires persons to submit a significant new use notice (SNUN) to EPA at least 90 days before they manufacture or process the chemical substance for that use (15 U.S.C. 2604(a)(1)(B)(i)). TSCA furthermore prohibits such manufacturing or processing from 
commencing until EPA has conducted a review of the notice, made an appropriate determination, and taken such actions as are required in association with that determination (15 U.S.C. 2604(a)(1)(B) ii)). In the case of a determination other than not likely to present unreasonable risk, the applicable review period must also expire before manufacturing or processing for the new use may commence. 
C. Applicability of General Provisions 
General provisions for SNURs appear 
in 40 CFR part 721, subpart A. These 
provisions describe persons subject to the proposed rule, recordkeeping requirements, exemptions to reporting requirements, and applicability of the rule to uses occurring before the effective date of the rule. Provisions relating to user fees appear at 40 CFR part 700. According to 40 CFR 721.1(c), persons subject to these SNURs must comply with the same SNUN requirements and EPA regulatory 
procedures as submitters of PMNs under TSCA section 5(a)(1)(A). These requirements include the information submission requirements of TSCA section 5(b) and 5(d)(1), the exemptions authorized by TSCA section 5(h)(1), (h)(2), (h)(3), and (h)(5), and the regulations at 40 CFR part 720. Once EPA receives a SNUN, EPA must either determine that the use is not likely to present an unreasonable risk of injury under the conditions of use for the chemical substance or take such regulatory action as is associated with an alternative determination before the manufacture or processing for the significant new use can commence. In the case of a determination other than not likely to present unreasonable risk, the applicable review period must also expire before manufacturing or processing for the new use may commence. If EPA determines that the use is not likely to present an unreasonable risk, EPA is required under TSCA section 5(g) to make public, and submit for publication in the Federal Register, a statement of EPA’s findings. 
III. Significant New Use Determination 
TSCA section 5(a)(2) states that EPA’s 
determination that a use of a chemical 
substance is a significant new use must be made after consideration of all relevant factors, including: 
•The projected volume of 
manufacturing and processing of a chemical substance. 
•The extent to which a use changes 
the type or form of exposure of human 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00052 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26421 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
beings or the environment to a chemical 
substance. 
•The extent to which a use increases 
the magnitude and duration of exposure of human beings or the environment to a chemical substance. 
•The reasonably anticipated manner 
and methods of manufacturing, processing, distribution in commerce, and disposal of a chemical substance. 
In determining what would constitute 
a significant new use for the chemical substances that are the subject of these SNURs, EPA considered relevant information about the toxicity of the chemical substances, likely human exposures and environmental releases associated with possible uses, and the four TSCA section 5(a)(2) factors listed in this unit. These proposed rules include PMN substances that are subject to Orders issued under TSCA section 5(e)(1)(A), as required by the determinations made under TSCA section 5(a)(3)(B). Those Orders require protective measures to limit exposures or otherwise mitigate the potential unreasonable risk. The proposed SNURs would identify as significant new uses any manufacturing, processing, use, distribution in commerce, or disposal that does not conform to the restrictions imposed by the underlying Orders, consistent with TSCA section 5(f)(4). 
IV. Substances Subject to This Proposed 
Rule 
EPA is proposing significant new use 
and recordkeeping requirements for certain chemical substances in 40 CFR part 721, subpart E. In this unit, EPA provides the following information for each chemical substance: 
•PMN number. 
•Chemical name (generic name, if 
the specific name is claimed as CBI). 
•Chemical Abstracts Service (CAS) 
Registry number (if assigned for non- confidential chemical identities). 
•Effective date of and basis for the 
TSCA section 5(e) Order. 
•Potentially Useful Information. 
•CFR citation assigned in the 
regulatory text section of the proposed rule. 
These proposed rules include PMN 
substances that are subject to Orders issued under TSCA section 5(e)(1)(A), as required by the determinations made under TSCA section 5(a)(3)(B). Those Orders require protective measures to limit exposures or otherwise mitigate the potential unreasonable risk. The proposed SNURs would identify as significant new uses any manufacturing, processing, use, distribution in commerce, or disposal that does not conform to the restrictions imposed by the underlying Orders, consistent with TSCA section 5(f)(4). 
Where EPA determined that the PMN 
substance may present an unreasonable risk of injury to human health via inhalation exposure, the underlying TSCA section 5(e) Order usually requires that potentially exposed employees wear specified respirators unless actual measurements of the workplace air show that air-borne concentrations of the PMN substance are below a New Chemical Exposure Limit (NCEL), include requirements addressing performance criteria for sampling and analytical methods, periodic monitoring, respiratory protection, and recordkeeping. No comparable NCEL provisions currently exist in 40 CFR part 721, subpart B, for SNURs. Therefore, for these cases, the individual SNURs in 40 CFR part 721, subpart E, will state that persons subject to the SNUR who wish to pursue NCELs as an alternative to the 40 CFR 721.63 respirator requirements may request to do so under 40 CFR 721.30. EPA expects that persons whose 40 CFR 721.30 requests to use the NCELs approach for SNURs that are approved by EPA will be required to comply with NCELs provisions that are comparable to those contained in the corresponding TSCA section 5(e) Order for the same chemical substance. 
The chemicals subject to these 
proposed SNURs are as follows: 
PMN Number: P–14–865 
Chemical Name: Aromatic amide 
oxime (generic). 
CAS Number: Not available. 
Effective date of TSCA section 5(e) 
Order: September 6, 2018. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the PMN substance will be as an intermediate. EPA identified concerns for mutagenicity based on analysis of test data on analogs. EPA also identified concerns for toxicity to fish based on analysis of test data on the PMN substance. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(I)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the TSCA Order requires: 
•Use of personal protective 
equipment (where there is potential for dermal exposure); 
•Use of the PMN substance only as 
a chemical intermediate; and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of 
the PMN substance into the waters of the United States exceeding a surface water concentration of 30 parts per billion (ppb). 
The SNUR designates as a ‘‘significant 
new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information may be potentially useful to characterize the effects of the PMN substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is 
considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has also determined that the results of specific reproductive/developmental testing and chronic aquatic toxicity testing would help characterize the potential human and environmental effects of the PMN substance. Although the Order does not require these tests, the Order’s restrictions remain in effect until the Order is modified or revoked by EPA based on submission of this or relevant information. 
CFR citation: 40 CFR 721.11466. 
PMN Number: P–15–54 
Chemical Name: Carbon nanotubes 
(generic). 
CAS Number: Not available. 
Effective Date of TSCA section 5(e) 
Order: December 17, 2019. 
Basis for TSCA section 5(e) Order: 
The PMN states that the use of the PMN 
substance will be as a chemical intermediate to manufacture functionalized carbon nanotubes by oxidation with nitric acid; an additive in rubber polymers to improve mechanical/physical/chemical/ electrical properties; an additive in resin polymers to improve mechanical/ physical/chemical/electrical properties; an additive in metals to improve electrical/thermal properties; an additive in ceramics to improve mechanical/electrical/thermal properties; a semi-conductor, conductive, or resistive element in electronic circuitry and devices; an electric collector element or electrode in energy devices; a photoelectric or thermoelectric conversion elements in energy devices; a catalyst support element or catalytic electrode for use in energy devices; an additive for transparency and conductivity in electronic devices; and an electro- mechanical element in actuator, sensor, or switching devices. Based on carbon nanotube analogues, data submitted for the PMN substance, and comparison to analogous respirable, poorly soluble particulates, EPA identified concerns for 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00053 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26422 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
pulmonary toxicity and oncogenicity. A 
direct final SNUR was issued for this PMN substance on November 17, 2016 (81 FR 81250), and withdrawn on January 19, 2017 (82 FR 6277) in response to the PMN submitter’s intent to submit adverse comments, which was a request to modify the original 5(e) Order to add more uses. The Order (as modified) was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the TSCA Order requires: 
•Use of personal protective 
equipment where there is a potential for dermal exposure; 
•Use of a National Institute for 
Occupational Safety and Health (NIOSH)-certified respirator with an Assigned Protection Factor (APF) of at least 50 where there is a potential for inhalation exposure; 
•Use of the PMN substance other 
than as allowed in the TSCA Order; 
•Waste streams from manufacture, 
processing, and use must be disposed of only by incineration or landfill; and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ in the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the environmental effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has determined that the results of chronic aquatic toxicity testing, with NOM (natural organic matter) as the dispersant, may be potentially useful to characterize the environmental effects of the PMN substance. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citation: 40 CFR 721.11467. 
PMN Number: P–16–583 
Chemical Name: Aromatic 
hydrocarbon resin (generic). 
CAS Number: Not available. 
Effective date of TSCA section 5(e) 
Order: October 17, 2018. Basis for TSCA section 5(e) Order: 
The PMN states that the use of the PMN 
substance will be as a sealant for head lamps of cars. EPA identified concern for hydrocarbon pneumonia if the PMN substance is manufactured with a higher proportion of lower molecular weight species during heating. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(I)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health. To protect against these risks, the TSCA Order requires: 
•Manufacture of the PMN substance 
such that the number average molecular weight is at least 1,000 grams per mole; and 
•Use of the PMN substance only as 
a hot-melt sealant for motor vehicle lamps. 
The SNUR designates as a ‘‘significant 
new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the health effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has also determined that the results of specific organ toxicity testing would help characterize the potential human health effects of the PMN substance. Although the Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or relevant information. 
CFR citation: 40 CFR 721.11468. 
PMN Number: P–17–193 
Chemical Names: Pentaerythritol ester 
of mixed linear and branched carboxylic acids (generic) (P–17–193, chemical A) and Dipentaerythritol ester of mixed linear and branched carboxylic acids (generic) (P–17–193, chemical B). 
CAS Numbers: Not available. 
Effective Date of TSCA section 5(e) 
Order: January 8, 2020. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the PMN substances will be as a synthetic lubricant for contained use and as an industrial lubricant. Based on analogue data, EPA has identified concerns for reproductive/developmental effects, systemic toxicity, and kidney effects. Based on comparison to analogous esters, EPA predicts drinking water toxicity may occur at concentrations that exceed 330 ppb. The Order was 
issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a 
reasoned evaluation, the substance may present an unreasonable risk of injury to human health or the environment. To protect against these risks, the TSCA Order requires: 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substances into the waters of the United States exceeding a surface water concentration of 330 ppb. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ in the absence this protective measure. 
Potentially Useful Information: EPA 
has determined that certain information about the human health effects of the PMN substances may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of in vitro toxicokinetics/metabolism information, specific target organ toxicity, and reproductive/development toxicity testing may be potentially useful to characterize the human health effects of the PMN substances. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citations: 40 CFR 721.11469 (P– 
17–193, chemical A) and 40 CFR 721.11470 (P–17–193, chemical B). 
PMN Number: P–17–221 
Chemical name: Alkylheterocyclic 
amine blocked isocyanate, alkoxysilane 
polymer (generic). 
CAS number: Not available. 
Effective date of TSCA section 5(e) 
Order: October 17, 2018. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the PMN substance will be as a coating polymer. Based on analysis of test data on reactivity of the methoxy and ethoxy silane moieties as well as the release of methanol, EPA identified concerns for ocular toxicity, irritation to eyes, skin, lung, and mucous membranes. The TSCA Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the in the absence of sufficient information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health and the 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00054 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26423 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
environment. To protect against these 
risks, the TSCA Order requires: 
•Use of personal protective 
equipment including chemically impervious gloves and eye goggles, (where there is potential for dermal exposure); 
•No use of the PMN substance at a 
concentration greater than 10% in formulation; 
•Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the Safety Data Sheet (SDS); and 
•Use of the PMN substance only for 
the confidential use allowed in the TSCA Order. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the health effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has also determined that the results of specific irritation and lung effect testing would help characterize the potential human effects of the PMN substance. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or relevant information. 
CFR citation: 40 CFR 721.11471. 
PMN Number: P–17–282 
Chemical Name: Isocyanic acid, 
polymethylenepolyphenylene ester, caprolactam- and phenol-blocked. 
CAS Number: 2093945–13–0. 
Effective Date of TSCA section 5(e) 
Order: January 13, 2020. 
Basis for TSCA section 5(e) Order: 
The PMN states that the use of the PMN 
substance will be as a blocked crosslinker for electrical insulation coating used on stators and motors. Based on the release of phenol, EPA has identified concerns for irritation to membranes, blood toxicity, and developmental toxicity. Based on the release of caprolactam, EPA has also identified concerns for eye, skin, and respiratory irritation, skin and respiratory sensitization, lung effects, kidney toxicity, and developmental toxicity. Based on comparison to analogous carbamate esters-phenyl and carbonyl ureas, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb. The TSCA Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the TSCA Order requires: 
•No modification of the 
manufacture, processing, or use of the PMN substance in any manner that generates inhalation exposure to phenol or caprolactam; and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States exceeding a surface water concentration of 1 ppb. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ in the absence of these protective measures. 
Potentially Useful Information: EPA 
has determined that certain information about the human health and environmental effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of aquatic toxicity, developmental toxicity, pulmonary effects, eye damage, skin irritation/corrosion, and skin sensitization testing may be potentially useful to characterize the human health and environmental effects of the PMN substance. Although the Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citation: 40 CFR 721.11472. 
PMN Number: P–17–334 
Chemical Name: Benzamide, 2- 
(trifluoromethyl)-. 
CAS Number: 360–64–5. 
Effective date of TSCA section 5(e) 
Order: August 20, 2018. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the PMN substance will be as a chemical precursor. EPA has identified concerns for neurotoxic effects based on analog data. There are concerns for oncogenicity based on test data. To the extent the chemical substance is metabolized, there are concerns for reproductive, developmental and neurotoxicity, lung, neurotoxicity, liver, and kidney effects based on analog data for the potential derivative metabolite. Based on analogous amides, EPA predicts environmental effects may occur at surface water concentrations that exceed 39 parts per billion. The TSCA Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) based on a finding that the substances may present an unreasonable risk of injury to human health or the environment. To protect against these risks, the TSCA Order requires: 
•No domestic manufacture of the 
PMN substance; 
•Use of personal protective 
equipment (where there is potential for dermal exposure); Establishment and use of a hazard communication program, including human health precautionary statements on each label and in the SDS; 
•Import for processing and use only 
as a chemical intermediate, as required by the Order, with no alteration of processes that result in the generation of a dust, mist or aerosol; and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States exceeding a surface water concentration of 39 ppb. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the health and environmental effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has also determined that the results of specific absorption and metabolism testing and chronic aquatic toxicity testing would help characterize the potential human and environmental effects of the PMN substance. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or relevant information. 
CFR citation: 40 CFR 721.11473. 
PMN Number: P–17–386 
Chemical Name: Cashew, nutshell liq. 
polymer with formaldehyde, phenol and resorcinol. 
CAS Number: 2044014–81–3. 
Effective date of TSCA section 5(e) 
Order: October 19, 2018. 
Basis for TSCA section 5(e) Order: 
The PMN states that the use of the 
substance will be as an additive as a processing aid for automotive tire stock 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00055 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26424 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
(tackifier for synthetic automotive tire 
stock). EPA identified concerns for sensitization based on resorcinol and cashew nutshell oil. The TSCA Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(I)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health. The TSCA Order was also issued under TSCA sections 5(a)(3)(B)(ii)(II) and 5(e)(1)(A)(ii)(II), based on a finding that the substance is or will be produced in substantial quantities and that the substance either enters or may reasonably be anticipated to enter the environment in substantial quantities, or there is or may be significant (or substantial) human exposure to the substance. To protect against these risks, the TSCA Order requires: 
•Submission to EPA of certain 
toxicity testing within 12 months of submission of a Notice of Commencement or Manufacture or Import (NOC) for the PMN substance; 
•Use of personal protective 
equipment (where there is potential for dermal exposure); 
•Use of a NIOSH-certified respirator 
with an APF of at least 50 (where there is a potential for inhalation exposure); and 
•No use of the PMN substance in a 
consumer product. 
The SNUR designates as a ‘‘significant 
new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the health effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has also determined that the results of specific sensitization testing would help characterize the potential human effects of the PMN substance. The submitter has agreed not to exceed a certain production volume limit without performing an acute aquatic toxicity testing. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or relevant information. 
CFR citation: 40 CFR 721.11474. 
PMN Number: P–18–12 
Chemical Name: Polyester polyol 
(generic). 
CAS Number: Not available. Effective Date of TSCA section 5(e) 
Order: January 30, 2020. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- confidential) use will be as adhesives. Based on the chelation of calcium to form calculi, EPA has identified concern for bladder toxicity. Based on comparison to analogous esters, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation, the substance may present an unreasonable risk of injury to human health or the environment. To protect against these risks, the TSCA Order requires: 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States exceeding a surface water concentration of 1 ppb. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ in the absence of this protective measure. 
Potentially Useful Information: EPA 
has determined that certain information about the human health and environmental effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of acute ecotoxicity base set, chronic ecotoxicity base set, and specific target organ toxicity testing may be potentially useful to characterize the human health and environmental effects of the PMN substance. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citation: 40 CFR 721.11475. 
PMN Number: P–18–18 
Chemical Name: Fluorinated acrylate, 
polymer with alkyloxirane homopolymer monoether with alkanediol mono(2-methyl-2- propenoate), tert-Bu 2- ethylhexaneperoxoate-initiated (generic). 
CAS Number: Not available. 
Effective date of TSCA section 5(e) 
Order: October 3, 2019. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the PMN substance will be as a lubricant. Based on estimated physical/chemical properties 
of the PMN substance, comparison to structurally analogous chemical substances, and structural alerts for perfluoro compounds, EPA has 
identified lung effects and systemic effects. Based on structural alerts for peroxides and acrylates, EPA has also identified skin sensitization. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of specific information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health or the environment. To protect against these risks, the TSCA Order requires: 
•No manufacture (including import) 
of the PMN substance beyond the confidential annual production volume; 
•Refrain from domestic manufacture 
of the PMN substance (i.e., import only); 
•Refrain from manufacturing, 
processing, distributing in commerce or using the PMN substance in a manner that would result in the generation of respirable forms (i.e., mist, vapor, or 
aerosol); and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information may be potentially useful to characterize the human health effects of the PMN substance in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of skin sensitization and specific target organ toxicity testing would help characterize the potential health effects of the PMN substance. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or relevant information. 
CFR citation: 40 CFR 721.11476. 
PMN Number: P–18–42 
Chemical name: 2,5-Furandione, 
polymer with 2-ethyl-2- (hydroxymethyl)-1,3-propanediol, 3a,4,5,6,7,7a-hexahydro-4,7-methano- 1H-inden-5(or 6)-yl ester, ester with 2,3- dihydroxypropyl neodecanoate, polymer with 5-isocyanato-1- (isocyanatomethyl)-1,3,3- trimethylcyclohexane, 2-hydroxyethyl 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00056 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26425 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
acrylate- and 2-hydroxyethyl 
methacrylate-blocked. 
CAS number: 2245262–16–0. 
Effective date of TSCA section 5(e) 
Order: September 19, 2018. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the PMN substance will be as an industrial coating. Based on analysis of test data on analogous acrylates, EPA identified concerns for mutagenicity, oncogenicity, developmental toxicity, liver toxicity, kidney toxicity, sensitization, and irritation. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) based on a finding that the substances may present an unreasonable risk of injury to human health or the environment. To protect against these risks, the TSCA Order requires: 
•Use of personal protective 
equipment (where there is potential for dermal exposure); 
•No use of the PMN substance 
involving an application method that generates a dust, mist, spray or aerosol; 
•Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS; 
•Use of the PMN substance only for 
the confidential use allowed in the TSCA Order; and 
•No use of the PMN substance in a 
consumer product. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the health effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has also determined that the results of specific sensitization and developmental toxicity testing would help characterize the potential human effects of the PMN substance. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or relevant information. 
CFR citation: 40 CFR 721.11477. 
PMN Numbers: P–18–52 and P–18–53 
Chemical Names: Perfluoroalkyl 
ethyl- and vinyl-modified 
organopolysiloxane (generic). 
CAS Numbers: Not available. 
Effective date of TSCA section 5(e) 
Order: January 14, 2020. 
Basis for TSCA section 5(e) Order: 
The PMNs state that the generic (non- confidential) use of the PMN substances 
will be as coating agents. Based on high molecular weight insoluble polymers and polymers with perfluorinated tails, EPA has identified concern for lung effects (lung waterproofing and lung overload). Based on analogue data for the low molecular weight fraction, EPA has also identified concerns for thyroid, liver, and developmental toxicity. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation, the substances may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the TSCA Order requires: 
•Use of personal protective 
equipment to prevent dermal exposure where there is a potential for dermal exposure; 
•Use of a NIOSH-certified respirator 
with an APF of at least 1,000 where there is a potential for inhalation exposure or compliance with a NCEL of 0.0015 mg/m
3as an 8-hour time- 
weighted average (TWA) to prevent inhalation exposure; 
•Establishment of a hazard 
communication program, including human health precautionary statements on each label and in the SDS; 
•No domestic manufacture of the 
PMN substances (i.e., import only); 
•No import of the PMN substances 
beyond the annual production volumes of 420 kg for P–18–52 and 336 kg for P– 18–53; and 
The proposed SNUR would designate 
as a ‘‘significant new use’’ the absence of these protective measures. 
Potentially Useful Information: EPA 
has determined that certain information about the human health effects of the PMN substances may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has determined that the results of specific target organ toxicity, pulmonary effects, and reproductive toxicity testing may be potentially useful to characterize the human health effects of the PMN substances. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citations: 40 CFR 721.11478 (P– 
18–52) and 40 CFR 721.11479 (P–18– 53). PMN Number: P–18–62 
Chemical Name: Oxirane, 2,2′- 
[cyclohexylidenebis(4,1- phenyleneoxymethylene)]bis-. 
CAS Number: 13446–84–9. 
Effective Date of TSCA section 5(e) 
Order: January 29, 2020. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use will be for open, non- dispersive use in coatings specifically for the electronics fields. Based on structural alerts for epoxides, EPA has identified concerns for carcinogenicity and reproductive effects. Based on submitted test data on the PMN substance and comparison to structurally analogous chemical substances, EPA has also identified concerns for mutagenicity and kidney effects. Based on QSAR predictions for analogous epoxides and neutral organics, EPA also predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation, the substance may present an unreasonable risk of injury to human health or the environment. To protect against these ricks, the TSCA Order requires: 
•Use of personal protective 
equipment to prevent dermal exposure where there is a potential for dermal exposure; 
•Use of a NIOSH-certified respirator 
with an APF of at least 1,000 where there is a potential for inhalation exposure; 
•Establishment of a hazard 
communication program, including human health precautionary statements on each label and in the SDS; 
•No manufacture or processing of the 
PMN substance in any manner which generates inhalation exposures; 
•No use of the PMN substance other 
than as described in the PMN; and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States exceeding a surface water concentration of 1 ppb. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ in the absence of these protective measures. 
Potentially Useful Information: EPA 
has determined that certain information about the human health and environmental effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00057 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26426 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
considering submitting a SNUN for a 
significant new use that will be designated by this SNUR. EPA has determined that the results of aquatic toxicity, specific target organ toxicity, reproductive toxicity, and carcinogenicity testing may be potentially useful to characterize the human health and environmental effects of the PMN substance. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citation: 40 CFR 721.11480. 
PMN Numbers: P–18–74 and P–18–75 
Chemical Names: Saturated fatty acid, 
reaction products with cadmium zinc selenide sulfide and polymeric amine (generic) (P–18–74) and Saturated fatty acid, reaction products with cadmium zinc selenide sulfide, alkylamine and polymeric amine (generic) (P–18–75). 
CAS Numbers: Not available. 
Effective Date of TSCA section 5(e) 
Order: January 31, 2020. 
Basis for TSCA section 5(e) Order: 
The PMN for P–18–74 states that use 
will be as a chemical intermediate for a quantum dot used as an optical down- converter (50%), and quantum dot in an optical down-converter (50%). The PMN for P–18–75 states that use will be as a quantum dot used in an optical down-converter. Based on the physical/ chemical properties of the PMN substances and comparison to structurally analogous chemical substances, EPA has identified concerns for carcinogenicity, immunotoxicity, lung effects, dermal, ocular and respiratory irritation, and undesignated sensitization. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation, the substances may present an unreasonable risk of injury to human health or the environment. To protect against these risks, the TSCA Order requires: 
•No manufacture of the PMN 
substances with a cadmium percentage greater than the confidential value stated in the Order; 
•No use of the PMN substance P–18– 
74 other than as a chemical intermediate for a quantum dot used as an optical down-converter or as a quantum dot in an optical down-converter; 
•No use of the PMN substance P–18– 
75 other than as a quantum dot used in an optical down-converter; 
•No manufacture, processing, or use 
of the PMN substances in any manner which results in inhalation exposure; •Manufacture, process, or use the 
PMN substances only in liquid formulation; 
•Only dispose of the PMN 
substances by incineration in a permitted hazardous waste incinerator; 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States; 
•Use of dermal personal protective 
equipment where there is a potential for dermal exposure; and 
•Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ in the absence of these protective measures. 
Potentially Useful Information: EPA 
has determined that certain information about the human health and environmental effects of the PMN substances may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of eye damage, skin irritation, skin sensitization, pulmonary toxicity, specific target organ toxicity, carcinogenicity, and acute and chronic aquatic toxicity testing may be potentially useful to characterize the human health and environmental effects of the PMN substances. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citations: 40 CFR 721.11481 (P– 
18–74) and 40 CFR 721.11482 (P–18– 75). 
PMN Number: P–18–160 
Chemical name: Heteropolycyclic, 
halo substituted alkyl substituted- 
diaromatic amino substituted carbomonocycle, halo substituted alkyl substituted heteropolycyclic, tetraaromatic metalloid salt (1:1) (generic). 
CAS number: Not available. 
Effective date of TSCA section 5(e) 
Order: December 10, 2019. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substance will be as a coating component. EPA identified concerns for acute toxicity, neurotoxicity, eye irritation, and photosensitization based on physical/ chemical properties and comparison to analogous chemical substances. EPA has also identified concerns for aquatic toxicity based on comparison to analogous cationic dyes. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the TSCA Order requires: 
Submission to EPA of certain toxicity 
testing before manufacturing the chemical for more than 18 months; 
•Use of personal protective 
equipment where there is a potential for dermal exposure; 
•Use of a NIOSH-certified respirator 
with an APF of at least 50 to prevent inhalation exposure where there is a potential for inhalation exposure; 
•Establishment of a hazard 
communication program, including health precautionary statements on each label and in the SDS; 
•Refraining from domestic 
manufacture in the United States (i.e., import only); 
•Refraining from manufacturing the 
PMN substance beyond the confidential annual manufacture (which includes import) production volume specified in the TSCA Order; 
•Refraining from manufacturing the 
PMN substance in the form of a powder, liquid or gas (i.e., solid only); and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ the absence protective measures. 
Potentially useful information: EPA 
has determined that certain information about the environmental and health effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. The submitter has agreed not to exceed certain production volume limits without performing the combined repeated dose toxicity with reproduction/developmental toxicity screening test with functional observation battery test. EPA has also determined that the results of chronic aquatic toxicity, acute toxicity, eye irritation, specific target organ toxicity, and photosensitization testing may be potentially useful to characterize the environmental and human health effects 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00058 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26427 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
of the PMN substance. Although the 
TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citation: 40 CFR 721.11483 
PMN Numbers: P–18–237 and P–18–292 
Chemical Names: Alkanediol, 
polymer with 5-isocyanato-1- (isocyanatomethyl)-1,3,3- trimethylcyclohexane, alkylaminoalkyl methacrylate- and dialkylheteromonocycle-blocked (generic) (P–18–237) and Alkanediol, polymer with 5-isocyanato-1- (isocyanatomethyl)-1,3,3- trimethylcyclohexane, alkylaminoalkyl methacrylate-blocked (generic) (P–18– 292). 
CAS Numbers: Not available. 
Effective date of TSCA section 5(e) 
Order: September 17, 2019. 
Basis for TSCA section 5(e) Order: 
The PMNs state that the generic (non- 
confidential) use of the PMN substances will be for use in print resins. Based on estimated physical/chemical properties of the PMN substances, comparison to structurally analogous chemical substances, and structural alerts for methacrylates, EPA has identified eye and skin irritation, skin sensitization, and systemic effects. Based on the comparison to structurally analogous acrylates/methacrylates, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of specific information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health or the environment. To protect against these risks, the TSCA Order requires: 
•No manufacturing, processing, or 
use of the PMN substances in any manner or method that generates dust, spray, vapor, mist, or aerosol; and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States exceeding a surface water concentration of 1 ppb. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information may be potentially useful to characterize the human health and environmental effects of the PMN substances if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of chronic aquatic toxicity, eye irritation, skin irritation, skin sensitization, and specific target organ toxicity testing would help characterize the potential health and environmental effects of the PMN substances. 
CFR citations: 40 CFR 721.11484 (P– 
18–237) and 40 CFR 721.11485 (P–18– 292). 
PMN Number: P–18–287 
Chemical Name: Synthetic oil from 
tires (generic). 
CAS Number: Not available. 
Effective Date of TSCA section 5(e) 
Order: December 17, 2019. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substance will be to produce ‘‘tires, wastes, pyrolyzed, condensate oil fraction’’ (CASRN 1312024–02–4) from scrap tire materials. The synthetic oil fraction from tire waste pyrolysis can be used in a variety of industries. Some examples of use of synthetic oil include use as a fuel, upgraded for use as a higher quality fuel, as an additive for asphalt or other complex mixtures, used to manufacture other chemicals, etc. EPA has identified concerns for irritation and neurotoxicity based on structural alerts for solvents, and systemic toxicity, developmental/reproductive toxicity, and carcinogenicity based on a constituent of the new chemical, benzene. EPA has also identified aspiration hazard based on measured kinematic viscosity. Based on SAR analysis of analogous neutral organics, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 5 ppb. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the TSCA Order requires: 
•No manufacture of the PMN 
substance other than as described in the PMN; 
•No manufacturing, processing, or 
use of the PMN substance for consumer or ‘‘commercial uses’’ (as the term is defined at 40 CFR 721.3) when the saleable goods or service could introduce the PMN substance into a ‘‘consumer’’ setting (as that term is defined in 40 CFR 721.3); and 
•Waste streams from manufacture, 
processing, and use must be disposed of only by incineration. The proposed SNUR would designate 
as a ‘‘significant new use’’ in the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the environmental and health effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has determined that the results of aquatic toxicity, skin irritation, eye irritation, specific target organ toxicity, reproductive toxicity (developmental effects), and carcinogenicity testing may be potentially useful to characterize the environmental and human health effects of the PMN substance. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citation: 40 CFR 721.11486. 
PMN Number: P–19–51 
Chemical name: 1,3-Propanediamine, 
N1,N1-dimethyl-, polymers with alkylene glycol ether with alkyltriol (3:1) mixed acrylates and adipates, and alkylene glycol monoacrylate ether with alkyltriol (3:1) (generic). 
CAS number: Not available. 
Effective date of TSCA section 5(e) 
Order: October 22, 2019. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substance will be as a UV curable ink. EPA has identified concerns for skin and respiratory sensitization and skin and eye irritation based on the methacrylate/ acrylate composition. EPA also identified liver effects based on the extent the low molecular weight fractions are bioavailable. Based on comparison to analogous polycationic polymers, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 3 ppb. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation, the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the TSCA Order requires: 
•Establishment of a hazard 
communication program, including human health precautionary statements on each label and in the SDS; 
•No domestic manufacture of the 
PMN substance (i.e., import only); 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00059 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26428 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
•No use of the PMN substance other 
than for the confidential use specified in 
the TSCA Order; and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States exceeding a surface water concentration of 3 ppb. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ the absence of these protective measures. 
Potentially Useful Information: EPA 
has determined that certain information may be potentially useful to characterize the human health and environmental effects of the PMN substance in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has determined that the results of acute and chronic aquatic toxicity, specific target organ toxicity, skin sensitization, skin irritation, and eye irritation testing would help EPA determine the potential human and environmental effects of the PMN substance. Although the TSCA Order does not require this information, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citation: 40 CFR 721.11487. 
PMN Number: P–19–55 
Chemical Name: 1,3-Propanediol, 2- 
ethyl-2-(hydroxymethyl)-, polymer with oxirane, 4-(dimethylamino)benzoate. 
CAS Number: 2067275–86–7. 
Effective Date of TSCA section 5(e) 
Order: January 14, 2020. 
Basis for TSCA section 5(e) Order: 
The PMN states that the use of the 
substance will be as a photo initiator within UV curable coating/ink formulations. Based on submitted test data, EPA has identified concerns for sensitization, reproductive, and systemic effects. Based on submitted acute and chronic toxicity data, EPA has also identified concern for toxicity to aquatic organisms may occur at concentrations that exceed 12 ppb. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the TSCA Order requires: 
•No manufacturing, processing, or 
use of the PMN substance in any manner that results in inhalation exposure; •No use of the PMN substance other 
than as a photo initiator within UV curable coating/ink formulations; and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States exceeding a surface water concentration of 12 ppb. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ in the absence of these protective measures. 
Potentially Useful Information: EPA 
has determined that certain information about the environmental effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has determined that the results of developmental/reproductive toxicity testing may be potentially useful to characterize the human health effects of the PMN substance. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citation: 40 CFR 721.11488. 
PMN Number: P–19–159 
Chemical Name: Titanium (4+) 
hydroxyl-alkylcarboxylate salt complex (generic). 
CAS Number: Not available. 
Effective Date of TSCA section 5(e) 
Order: January 10, 2020. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substance will be as a catalyst in the industrial sector. Based on the reactive nature of the PMN substance, presence of acid moieties, titanium (to the extent it is bioavailable), and information in the SDS, EPA has identified concerns for irritation to the eyes, skin, and respiratory tract, severe skin burns and eye damage, and skin and respiratory sensitization. Based on test data available on the PMN substance and comparison to analogous substances, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 1 ppb. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient information to permit a reasoned evaluation the substance may present an unreasonable risk of injury to human health and the environment. To protect against these risks, the TSCA Order requires: 
•No manufacture, processing, or use 
of the PMN substance in any manner or method that generates inhalation exposure; and 
•No predictable or purposeful 
release of a manufacturing, processing, or use stream associated with any use of the PMN substance into the waters of the United States exceeding a surface water concentration of 1 ppb. 
The proposed SNUR would designate 
as a ‘‘significant new use’’ in the absence of these protective measures. 
Potentially Useful Information: EPA 
has determined that certain information about the human health effects of the PMN substance may be potentially useful in support of a request by the PMN submitter to modify the TSCA Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this SNUR. EPA has determined that the results of pulmonary effects, skin irritation, eye irritation, skin sensitization, and specific target organ toxicity testing may be potentially useful to characterize the human health effects of the PMN substance. Although the TSCA Order does not require these tests, the TSCA Order’s restrictions remain in effect until the TSCA Order is modified or revoked by EPA based on submission of this or other relevant information. 
CFR citation: 40 CFR 721.11489. 
V. Rationale and Objectives of the Proposed Rule 
A. Rationale 
During review of the PMNs submitted 
for the chemical substances that are 
subject to these proposed SNURs, EPA concluded that regulation was warranted under TSCA section 5(e), pending the development of information sufficient to make reasoned evaluations of the health or environmental effects of the chemical substances. The basis for such findings is outlined in Unit IV. Based on these findings, TSCA section 5(e) Orders requiring the use of appropriate exposure controls were negotiated with the PMN submitters. As a general matter, EPA believes it is necessary to follow TSCA section 5(e) Orders with a SNUR that identifies the absence of those protective measures as Significant New Uses to ensure that all manufacturers and processors—not just the original submitter—are held to the same standard. 
B. Objectives 
EPA is proposing these SNURs for 
specific chemical substances which 
have undergone premanufacture review because the Agency wants: 
•To identify as significant new uses 
any manufacturing, processing, use, 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00060 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26429 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
distribution in commerce, or disposal 
that does not conform to the restrictions imposed by the underlying TSCA Orders, consistent with TSCA section 5(f)(4). 
•To have an opportunity to review 
and evaluate data submitted in a SNUN before the notice submitter begins manufacturing or processing a listed chemical substance for the described significant new use. 
•To be able to either determine that 
the prospective manufacture or processing is not likely to present an unreasonable risk, or to take necessary regulatory action associated with any other determination, before the described significant new use of the chemical substance occurs. 
VI. Applicability of the Proposed 
Significant New Use Designation 
To establish a significant new use, 
EPA must determine that the use is not ongoing. The chemical substances subject to this proposed rule have 
undergone premanufacture review. In cases where EPA has not received a notice of commencement (NOC) and the chemical substance has not been added to the TSCA Inventory, no person may commence such activities without first submitting a PMN. Therefore, for chemical substances for which an NOC has not been submitted EPA concludes that the designated significant new uses are not ongoing. 
When chemical substances identified 
in this proposed rule are added to the TSCA Inventory, EPA recognizes that, before the rule is effective, other persons might engage in a use that has been identified as a significant new use. However, TSCA section 5(e) Orders have been issued for these chemical substances, and the PMN submitters are prohibited by the TSCA section 5(e) Orders from undertaking activities which would be designated as significant new uses. The identities of 18 of the 24 chemical substances subject to this proposed rule have been claimed as confidential (per 40 CFR 720.85) for a chemical substance covered by this action. Based on this, the Agency believes that it is highly unlikely that any of the significant new uses described in the regulatory text of this proposed rule are ongoing. 
Therefore, EPA designates May 4, 
2020 as the cutoff date for determining whether the new use is ongoing. The objective of EPA’s approach is to ensure that a person cannot defeat a SNUR by initiating a significant new use before the effective date of the final rule. 
In the unlikely event that a person 
began commercial manufacture or processing of the chemical substances for a significant new use identified as of 
that date would have to cease any such activity upon the effective date of the final rule. To resume their activities, these persons would have to first comply with all applicable SNUR notification requirements and wait until EPA has conducted a review of the notice, made an appropriate determination on the notice, and has taken such actions as are required with that determination. 
Issuance of a SNUR for a chemical 
substance does not signify that the chemical substance is listed on the TSCA Chemical Substance Inventory (TSCA Inventory). Guidance on how to determine if a chemical substance is on the TSCA Inventory is available on the internet at http://www.epa.gov/opptintr/ existingchemicals/pubs/tscainventory/ index.html. 
VII. Development and Submission of 
Information 
EPA recognizes that TSCA section 5 
does not require developing any particular new information (e.g., generating test data) before submission of a SNUN. There is an exception: If a person is required to submit information for a chemical substance pursuant to a rule, Order or consent agreement under TSCA section 4 (15 U.S.C. 2603), then TSCA section 5(b)(1)(A) (15 U.S.C. 2604(b)(1)(A)) requires such information to be submitted to EPA at the time of submission of the SNUN. 
In the absence of a rule, Order, or 
consent agreement under TSCA section 4 covering the chemical substance, persons are required only to submit information in their possession or control and to describe any other information known or reasonably ascertainable (40 CFR 720.50). However, upon review of PMNs and SNUNs, the Agency has the authority to require appropriate testing. Unit IV. lists potentially useful information for all 
SNURs listed here. Descriptions of this information is provided for informational purposes. The potentially useful information identified in Unit IV of the proposed rule will be useful to EPA’s evaluation in the event that someone submits a SNUN for the significant new use. Companies who are considering submitting a SNUN are encouraged, but not required, to develop the information on the substance, which may assist with EPA’s analysis of the SNUN. EPA strongly encourages persons, before performing any testing, to consult with the Agency. Furthermore, pursuant to TSCA section 4(h), which pertains to reduction of testing on vertebrate animals, EPA encourages dialog with the Agency on the use of alternative test methods and strategies (also called New Approach Methodologies, or NAMs), if available, to generate the potentially useful information. EPA encourages dialogue with Agency representatives to help determine how best the submitter can meet both the data needs and the objective of TSCA section 4(h). To access the OCSPP test guidelines referenced in this document electronically, please go to http://www.epa.gov/ocspp and select ‘‘Test 
Methods and Guidelines.’’ The Organisation for Economic Co-operation and Development test guidelines are available from the OECD Bookshop at http://www.oecdbookshop.org or 
SourceOECD at http://www.sourceoecd.org. 
The potentially useful information 
listed in Unit IV. may not be the only means of addressing the potential risks of the chemical substance. However, submitting a SNUN without any test data or other information may increase the likelihood that EPA will take action under TSCA section 5(e) or 5(f). EPA recommends that potential SNUN submitters contact EPA early enough so that they will be able to conduct the appropriate tests. 
SNUN submitters should be aware 
that EPA will be better able to evaluate SNUNs which provide detailed information on the following: 
•Human exposure and 
environmental release that may result from the significant new use of the chemical substances. 
•Information on risks posed by the 
chemical substances compared to risks posed by potential substitutes. 
VIII. SNUN Submissions 
According to 40 CFR 721.1(c), persons 
submitting a SNUN must comply with 
the same notification requirements and EPA regulatory procedures as persons submitting a PMN, including submission of test data on health and environmental effects as described in 40 CFR 720.50. SNUNs must be submitted on EPA Form No. 7710–25, generated using e-PMN software, and submitted to the Agency in accordance with the procedures set forth in 40 CFR 720.40. E–PMN software is available electronically at http://www.epa.gov/ opptintr/newchems. 
IX. Economic Analysis 
EPA has evaluated the potential costs 
of establishing SNUN requirements for 
potential manufacturers and processors of the chemical substances subject to this proposed rule. EPA’s complete economic analysis is available in the 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00061 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26430 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
docket under docket ID number EPA– 
HQ–OPPT–2019–0596. 
X. Statutory and Executive Order 
Reviews 
Additional information about these 
statutes and Executive Orders can be found at https://www.epa.gov/laws- 
regulations-and-executive-orders. 
A. Executive Order 12866: Regulatory 
Planning and Review and Executive Order 13563: Improving Regulations and Regulatory Review 
This proposed rule would establish 
SNURs for 3 new chemical substances that were the subject of PMNs. The Office of Management and Budget (OMB) has exempted these types of actions from review under Executive Order 12866 (58 FR 51735, October 4, 1993) and 13563 (76 FR 3821, January 21, 2011). 
B. Paperwork Reduction Act (PRA) 
According to the PRA, 44 U.S.C. 3501 
et seq., an Agency may not conduct or 
sponsor, and a person is not required to respond to a collection of information that requires OMB approval under PRA, unless it has been approved by OMB and displays a currently valid OMB control number. The OMB control numbers for EPA’s regulations in title 40 of the CFR, after appearing in the Federal Register, are listed in 40 CFR part 9, and included on the related collection instrument or form, if applicable. 
The information collection 
requirements related to this action have already been approved by OMB pursuant to PRA under OMB control number 2070–0012 (EPA ICR No. 574). This action does not impose any burden requiring additional OMB approval. If an entity were to submit a SNUN to the Agency, the annual burden is estimated to average between 30 and 170 hours per response. This burden estimate includes the time needed to review instructions, search existing data sources, gather and maintain the data needed, and complete, review, and submit the required SNUN. 
Send any comments about the 
accuracy of the burden estimate, and any suggested methods for minimizing respondent burden, including through the use of automated collection techniques, to the Director, Regulatory Support Division, Office of Mission Support (2822T), Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001. Please remember to include the OMB control number in any correspondence, but do not submit any completed forms to this address. C. Regulatory Flexibility Act (RFA) 
Pursuant to section 605(b) of the RFA, 
5 U.S.C. 601 et seq., the Agency hereby certifies that promulgation of this proposed SNUR would not have a significant adverse economic impact on a substantial number of small entities. The requirement to submit a SNUN applies to any person (including small or large entities) who intends to engage in any activity described in the final rule as a ‘‘significant new use.’’ Because these uses are ‘‘new,’’ based on all information currently available to EPA, it appears that no small or large entities presently engage in such activities. A SNUR requires that any person who intends to engage in such activity in the future must first notify EPA by submitting a SNUN. Although some small entities may decide to pursue a significant new use in the future, EPA cannot presently determine how many, if any, there may be. However, EPA’s experience to date is that, in response to the promulgation of SNURs covering over 1,000 chemicals, the Agency receives only a small number of notices per year. For example, the number of SNUNs received was seven in Federal fiscal year (FY) 2013, 13 in FY2014, six in FY2015, 12 in FY2016, 13 in FY2017, and 11 in FY2018, only a fraction of these were from small businesses. In addition, the Agency currently offers relief to qualifying small businesses by reducing the SNUN submission fee from $16,000 to $2,800. This lower fee reduces the total reporting and recordkeeping of cost of submitting a SNUN to about $10,116 for qualifying small firms. Therefore, the potential economic impacts of complying with this proposed SNUR are not expected to be significant or adversely impact a substantial number of small entities. In a SNUR that published in the Federal Register of June 2, 1997 (62 FR 29684) 
(FRL–5597–1), the Agency presented its general determination that final SNURs are not expected to have a significant economic impact on a substantial number of small entities, which was provided to the Chief Counsel for Advocacy of the Small Business Administration. 
D. Unfunded Mandates Reform Act 
(UMRA) 
Based on EPA’s experience with 
proposing and finalizing SNURs, State, local, and Tribal governments have not been impacted by these rulemakings, and EPA does not have any reasons to believe that any State, local, or Tribal government will be impacted by this proposed rule. As such, EPA has determined that this proposed rule does not impose any enforceable duty, 
contain any unfunded mandate, or otherwise have any effect on small governments subject to the requirements of UMRA sections 202, 203, 204, or 205 (2 U.S.C. 1531–1538 et seq.). 
E. Executive Order 13132: Federalism 
This action would not have a 
substantial direct effect on States, on the 
relationship between the national government and the States, or on the distribution of power and responsibilities among the various levels of government, as specified in Executive Order 13132 (64 FR 43255, August 10, 1999). 
F. Executive Order 13175: Consultation 
and Coordination With Indian Tribal Governments 
This proposed rule would not have 
Tribal implications because it is not expected to have substantial direct effects on Indian Tribes. This proposed rule would not significantly nor uniquely affect the communities of Indian Tribal governments, nor does it involve or impose any requirements that affect Indian Tribes. Accordingly, the requirements of Executive Order 13175 (65 FR 67249, November 9, 2000), do not apply to this proposed rule. 
G. Executive Order 13045: Protection of 
Children From Environmental Health and Safety Risks 
This action is not subject to Executive 
Order 13045 (62 FR 19885, April 23, 1997), because this is not an economically significant regulatory action as defined by Executive Order 12866, and this action does not address environmental health or safety risks disproportionately affecting children. 
H. Executive Order 13211: Actions 
Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use 
This proposed rule is not subject to 
Executive Order 13211 (66 FR 28355, May 22, 2001), because this action is not expected to affect energy supply, distribution, or use and because this action is not a significant regulatory action under Executive Order 12866. 
I. National Technology Transfer and 
Advancement Act (NTTAA) 
In addition, since this action does not 
involve any technical standards, NTTAA section 12(d), 15 U.S.C. 272 note, does not apply to this action. 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00062 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26431 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
J. Executive Order 12898: Federal 
Actions To Address Environmental Justice in Minority Populations and Low-Income Populations 
This action does not entail special 
considerations of environmental justice related issues as delineated by Executive Order 12898 (59 FR 7629, February 16, 1994). 
List of Subjects 40 CFR Part 721 
Environmental protection, Chemicals, 
Hazardous substances, Reporting and 
recordkeeping requirements. 
Dated: April 13, 2020. 
Tala Henry, 
Deputy Director, Office of Pollution 
Prevention and Toxics. 
Therefore, it is proposed that 40 CFR 
chapter I be amended as follows: 
PARTS 721—[AMENDED] 
■1. The authority citation for part 721 
continues to read as follows: 
Authority: 15 U.S.C. 2604, 2607 and 
2625(c). 
■2. Add §§ 721.11466 through 
721.11489 to subpart E to read as 
follows: 
Subpart E—Significant New Uses for 
Specific Chemical Substances 
* * * * * 
Secs. 
721.11466 Aromatic amide oxime (generic). 721.11467 Carbon nanotubes (generic). 721.11468 Aromatic hydrocarbon resin 
(generic). 
721.11469 Pentaerythritol ester of mixed 
linear and branched carboxylic acids (generic) (P–17–193, chemical A). 
721.11470 Dipentaerythritol ester of mixed 
linear and branched carboxylic acids (generic) (P–17–193, chemical B). 
721.11471 Alkylheterocyclic amine blocked 
isocyanate, alkoxysilane polymer (generic). 
721.11472 Isocyanic acid, 
polymethylenepolyphenylene ester, caprolactam- and phenol-blocked. 
721.11473 Benzamide, 2-(trifluoromethyl)-. 721.11474 Cashew, nutshell liq. polymer 
with formaldehyde, phenol and resorcinol. 
721.11475 Polyester polyol (generic). 721.11476 Fluorinated acrylate, polymer 
with alkyloxirane homopolymer monoether with alkanediol mono(2- methyl-2-propenoate), tert-Bu 2- ethylhexaneperoxoate-initiated (generic). 
721.11477 2,5-Furandione, polymer with 2- 
ethyl-2-(hydroxymethyl)-1,3- propanediol, 3a,4,5,6,7,7a-hexahydro- 4,7-methano-1H-inden-5(or 6)-yl ester, ester with 2,3-dihydroxypropyl neodecanoate, polymer with 5- isocyanato-1-(isocyanatomethyl)-1,3,3- trimethylcyclohexane, 2-hydroxyethyl acrylate- and 2-hydroxyethyl 
methacrylate-blocked. 
721.11478 Perfluoroalkyl ethyl- and vinyl- 
modified organopolysiloxane (generic). 
721.11479 Perfluoroalkyl ethyl- and vinyl- 
modified organopolysiloxane (generic). 
721.11480 Oxirane, 2,2′- 
[cyclohexylidenebis(4,1- phenyleneoxymethylene)]bis-. 
721.11481 Saturated fatty acid, reaction 
products with cadmium zinc selenide sulfide and polymeric amine (generic). 
721.11482 Saturated fatty acid, reaction 
products with cadmium zinc selenide sulfide, alkylamine and polymeric amine (generic). 
721.11483 Heteropolycyclic, halo 
substituted alkyl substituted- diaromatic amino substituted carbomonocycle, halo substituted alkyl substituted heteropolycyclic, tetraaromatic metalloid salt (1:1) (generic). 
721.11484 Alkanediol, polymer with 5- 
isocyanato-1-(isocyanatomethyl)-1,3,3- trimethylcyclohexane, alkylaminoalkyl methacrylate-, and dialkylheteromonocycle-blocked (generic). 
721.11485 Alkanediol, polymer with 5- 
isocyanato-1-(isocyanatomethyl)-1,3,3- trimethylcyclohexane, alkylaminoalkyl methacrylate-blocked (generic). 
721.11486 Synthetic oil from tires (generic). 721.11487 1,3-Propanediamine, N1,N1- 
dimethyl-, polymers with alkylene glycol ether with alkyltriol (3:1) mixed acrylates and adipates, and alkylene glycol monoacrylate ether with alkyltriol (3:1) (generic). 
721.11488 1,3-Propanediol, 2-ethyl-2- 
(hydroxymethyl)-, polymer with oxirane, 4-(dimethylamino)benzoate. 
721.11489 Titanium (4+) hydroxyl- 
alkylcarboxylate salt complex (generic). 
* * * * * 
§ 721.11466 Aromatic amide oxime 
(generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as aromatic amide oxime (PMN P–14–865) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1) through (3), (b), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative 
control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(6), particulate (including solids or liquid droplets). For purposes of § 721.63(b), concentration is set at 1.0%. (ii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(g). 
(iii) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4) and, (c)(4) where N = 30. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (e), (i), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11467 Carbon nanotubes (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified generically as carbon nanotubes (PMN P–15–54) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the PMN substance that have been (i) embedded or incorporated into a polymer matrix that itself has been reacted (cured) or (ii) embedded in a permanent solid polymer form that is not intended to undergo further processing, except mechanical processing. 
(2) The significant new uses are: 
(i) Workplace protection. 
Requirements as specified in 
§ 721.63(a)(1), (2)(i) and (ii), (3), (4) through (6), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the 
operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 50. For purposes of § 721.63(a)(6), particulate (including solids or liquid droplets). 
(ii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k) (chemical intermediate to manufacture functionalized carbon nanotubes by oxidation with nitric acid; additive in rubber polymers to improve mechanical/physical/chemical/ electrical properties; additive in resin polymers to improve mechanical/ physical/chemical/electrical properties; 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00063 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26432 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
additive in metals to improve electrical/ 
thermal properties; additive in ceramics to improve mechanical/electrical/ thermal properties; semi-conductor, conductive, or resistive element in electronic circuitry and devices; electric collector element or electrode in energy devices; photoelectric or thermoelectric conversion elements in energy devices; catalyst support element or catalytic electrode for use in energy devices; additive for transparency and conductivity in electronic devices; and electro-mechanical element in actuator, sensor, or switching devices). 
(iii) Disposal. Requirements as 
specified in § 721.85(a)(1) and (2), (b)(1) and (2), and (c)(1) and (2). 
(iv) Release to water. Requirements as 
specified in § 721.90(a)(1), (b)(1), and (c)(1). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (e), and (i) through (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11468 Aromatic hydrocarbon resin 
(generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as aromatic hydrocarbon resin (PMN P–16–583) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (hot-melt sealant for motor vehicle lamps). It is a significant new use to manufacture the PMN substance with an average number molecular weight of less than 1000 grams per mole. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11469 Pentaerythritol ester of mixed 
linear and branched carboxylic acids (generic) (P–17–193, chemical A). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as pentaerythritol ester of mixed linear and branched carboxylic acids (PMN P–17–193, chemical A) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. 
(2) The significant new use is: 
(i) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and 
(c)(4) where N = 330. 
(ii) [Reserved] 
(b) Specific requirements. The 
provision of subpart A of this part apply 
to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain modification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11470 Dipentaerythritol ester of 
mixed linear and branched carboxylic acids (generic) (P–17–193, chemical B). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as dipentaerythritol ester of mixed linear and branched carboxylic acids (PMN P–17–193, chemical B) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. 
(2) The significant new use is: 
(i) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and 
(c)(4) where N = 330. 
(ii) [Reserved] 
(b) Specific requirements. The 
provision of subpart A of this part apply 
to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain modification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11471 Alkylheterocyclic amine 
blocked isocyanate, alkoxysilane polymer (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified 
generically as alkylheterocyclic amine blocked isocyanate, alkoxysilane polymer (PMN P–17–221) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this TSCA Order do not apply to quantities of the PMN substance after they have been completely reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3) and (6) (particulate), (b) (concentration set at 1.0%), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (d), (e) (concentration set at 1.0%), (f), (g)(1)(i) and (ii), (2)(i) through (iii), (v), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k). It is a significant new use to formulate the PMN to a concentration greater than 10%. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph. 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii). 
§ 721.11472 Isocyanic acid, 
polymethylenepolyphenylene ester, caprolactam- and phenol-blocked. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as isocyanic acid, polymethylenepolyphenylene ester, caprolactam- and phenol-blocked (PMN 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00064 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26433 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
P–17–282, CAS NO. 2093945–13–0) is 
subject to reporting under this section for the significant new uses described paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted (cured). 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. It is a significant 
new use to manufacture, process, or use the PMN substance in any manner or method that generates inhalation exposure to phenol or caprolactam. 
(ii) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N = 1. 
(b) Specific requirements. The 
provision of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), (i), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain modification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11473 Benzamide, 2- 
(trifluoromethyl)-. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as benzamide, 2-(trifluoromethyl)- (PMN P–17–334, CAS No. 360–64–5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (2)(i) and (iv), (3), (4), (6)(v) and (vi) (particulate), (b) (concentration set at 0.1%), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (d), (e) (concentration set at 0.1%), (f), (g)(1)(iii) through (v), and (ix), (2)(i) through (iii), and (v), (3)(i) and (ii), and (5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. (iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (g), and (y)(1). 
(iv) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N = 39. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph. 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11474 Cashew, nutshell liq. polymer 
with formaldehyde, phenol and resorcinol. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as cashew nutshell liq. polymer with formaldehyde, phenol and resorcinol (PMN P–17–386, CAS No. 2044014–81– 3) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (3) through (5), (6)(v) and (vi) ((particulate), (combination gas/ vapor and particulate)), (b) (concentration set at 1.0%), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 50. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (d), (e) (concentration set at 1.0%), (f), (g)(1)(i) (skin and respiratory sensitization), (2)(i), (ii), (iv), (v), (4)(iii), and (5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(o). It is a significant new use to manufacture the substance for more than one year. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11475 Polyester polyol (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified generically as polyester polyol (PMN P– 18–12) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and 
(c)(4) where N = 1. 
(ii) [Reserved] 
(b) Specific requirements. The 
provision of subpart A of this part apply 
to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain modification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11476 Fluorinated acrylate, polymer 
with alkyloxirane homopolymer monoether with alkanediol mono(2-methyl-2- propenoate), tert-Bu 2- ethylhexaneperoxoate-initiated (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as fluorinated acrylate, polymer with alkyloxirane homopolymer monoether with alkanediol mono(2-methyl-2- propenoate), tert-Bu 2- ethylhexaneperoxoate-initiated (PMN P–18–18) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(f), (t), and (y)(1). 
(ii) Releases to water. Requirements as 
specified in § 721.90(a)(1), (b)(1), and (c)(1). 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00065 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26434 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), (i), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 
§ 721.11477 2,5-Furandione, polymer with 
2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 3a,4,5,6,7,7ahexahydro- 4,7-methano-1H- inden-5(or 6)-yl ester, ester with 2,3- dihydroxypropyl neodecanoate, polymer with 5-isocyanato-l-(isocyanatomethyl)-1,3, 3-trimethylcyclohexane, 2-hydroxyethyl acrylate- and 2-hydroxyethyl methacrylate- blocked. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as 2,5-furandione, polymer with 2-ethyl-2- (hydroxymethyl)-1,3-propanediol, 3a,4,5,6,7,7ahexahydro- 4,7-methano- 1H-inden-5(or 6)-yl ester, ester with 2,3- dihydroxypropyl neodecanoate, polymer with 5-isocyanato-l- (isocyanatomethyl)-1,3, 3- trimethylcyclohexane, 2-hydroxyethyl acrylate- and 2-hydroxyethyl methacrylate-blocked (PMN P–18–42, CAS No. 2245262–16–0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the PMN substance after they have been completely reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (2)(i) through (iv), (3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (d), (f), (g)(1)(i), (ii), (iv), (vii), (ix) (eye irritation), (2)(i) through (iii), (v) (avoid eye contact), and (5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (o), and (y)(1). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph. 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii). 
§ 721.11478 Perfluoroalkyl ethyl- and vinyl- 
modified organopolysiloxane (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as perfluoroalkyl ethyl- and vinyl-modified organopolysiloxane (PMN P–18–52) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1) through (5), and (c). When determining which persons are reasonably likely to be exposed as required by § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 1,000), (6)(combination gas/vapor and particulate. 
(A) As an alternative to respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in TSCA section 5(e) consent order for this substance. The NCEL is 0.0015 mg/ m
3as an 8-hour time weighted average. 
Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA section 5(e) consent order. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (d), (f), (g)(1)(vi) (specific target organ toxicity), (2)(i) through (v), and (5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. For purposes of § 721.72(g)(2)(iv), use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0015 mg/m
3. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f) and (t) (420 kilograms). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain modification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11479 Perfluoroalkyl ethyl- and vinyl- 
modified organopolysiloxane (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as perfluoroalkyl ethyl- and vinyl-modified organopolysiloxane (PMN P–18–53) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (3) through (6) (combination gas/vapor and particulate), and (c). When determining which persons are reasonably likely to be exposed as required by § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the 
operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00066 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26435 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
(NIOSH) assigned protection factor 
(APF) of at least 1,000. 
(A) As an alternative to respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in TSCA section 5(e) consent order for this substance. The NCEL is 0.0015 mg/ m
3as an 8-hour time weighted average. 
Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA section 5(e) consent order. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (d), (f), (g)(1)(vi) (specific target organ toxicity), (2)(i) through (v), and (5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. For purposes of § 721.63(g)(2)(iv), use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0015 mg/m
3. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f) and (t) (336 kilograms). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain modification requirements. The provisions of § 1721.185 apply to this section. 
§ 721.11480 Oxirane, 2,2′- 
[cyclohexylidenebis(4,1- phenyleneoxymethylene)]bis-. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical identified as oxirane, 2,2′-[cyclohexylidenebis(4,1- phenyleneoxymethylene)]bis- (PMN P– 18–62, CAS No. 13446–84–9) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the PMN substance after they have been completely reacted (cured). 
(2) The significant new uses are: (i) Protection in the workplace. 
Requirements as specified in § 721.63(a)(1), (3) through (6) (particulate including solids or liquid droplets), (b) (concentration set at 0.1%), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the 
operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 1,000. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e) (concentration set at 0.1%), (f), (g)(1)(vi), (vii) (specific target organ toxicity), (2)(i) through (iii) (use respiratory protection when spraying), (v), (3)(i) and (ii), (4)(i), and (5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k). It is a significant new use to manufacture or process the PMN substance in any manner which generates inhalation exposures. 
(iv) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N = 1. 
(b) Specific requirements. The 
provision of subpart A of this part apply to this section as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain modification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11481 Saturated fatty acid, reaction 
products with cadmium zinc selenide sulfide and polymeric amine (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical identified generically as saturated fatty acid, reaction products with cadmium zinc selenide sulfide and polymeric amine (PMN P–18–74) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (3), (6) (particulate (including solids or liquid droplets), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (d), (f), (g)(1)(i), (vii) ((pulmonary toxicity), (eye damage), (specific target organ toxicity), (skin sensitization)), (2)(i) through (iii), and (v), (3)(i) and (ii), (4)(i) and (iii), and (5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k) (chemical intermediate for a quantum dot used as an optical down-converter (50%), and quantum dot in an optical down- converter (50%)). It is a significant new use to manufacture, process, or use the PMN substance in other than a liquid formulation. It is a significant new use to manufacture or process the PMN substance in any manner which generates inhalation exposures. It is a significant new use to manufacture the PMN substance with a cadmium percentage greater than the confidential level identified in the TSCA Order. 
(iv) Disposal. It is a significant new 
use to dispose of the PMN substance in any manner other than by incineration in a permitted hazardous waste incinerator. 
(v) Release to water. Requirements as 
specified in § 721.90(a)(1), (b)(1), and (c)(1). 
(b) Specific requirements. The 
provision of subpart A of this part apply to this section as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (d), and (f) through (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain modification requirements. The provisions of § 721.185 apply to this section. 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00067 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26436 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
(3) Determining whether a specific use 
is subject to this section. The provisions 
of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11482 Saturated fatty acid, reaction 
products with cadmium zinc selenide sulfide, alkylamine and polymeric amine (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical identified generically as saturated fatty acid, reaction products with cadmium zinc selenide sulfide, alkylamine and polymeric amine (PMN P–18–75) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (3), (6) (particulate (including solids or liquid droplets)), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (d), (f), (g)(1)(i), (vii) ((pulmonary toxicity), (eye damage), (specific target organ toxicity), (skin sensitization)), (2)(i) through (iii), and (v), (3)(i) and (ii), (4)(i) and (iii), and (5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k)(quantum dot in an optical down-converter). It is a significant new use to manufacture, process, or use the PMN substance in other than a liquid formulation. It is a significant new use to manufacture or process the PMN substance in any manner which generates inhalation exposures. It is a significant new use to manufacture the PMN substance with a cadmium percentage greater than the confidential value stated in the TSCA Order. 
(iv) Disposal. It is a significant new 
use to dispose of the PMN substance in any manner other than by incineration in a permitted hazardous waste incinerator. 
(v) Release to water. Requirements as 
specified in § 721.90(a)(1), (b)(1), and (c)(1). (b) Specific requirements. The 
provision of subpart A of this part apply 
to this section as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (d), and (f) through (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain modification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11483 Heteropolycyclic, halo 
substituted alkyl substituted- diaromatic amino substituted carbomonocycle, halo substituted alkyl substituted heteropolycyclic, tetraaromatic metalloid salt (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as heteropolycyclic, halo substituted alkyl substituted- diaromatic amino substituted carbomonocycle, halo substituted alkyl substituted heteropolycyclic, tetraaromatic metalloid salt (1:1) (PMN P–18–160) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (2)(i) through (iv), and (3) through (6) ((solids), (liquid droplets)). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 50. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (d), (f), (g)(1) ((acute toxicity), (neurotoxicity), (photosensitization), (eye irritation)), (2)(i) through (v), (3)(i) and (ii), and (4)(iii). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. (iii) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(f), (t), and (w)(1), (3), and (4). It is a significant new use to manufacture the substance for more than 18 months. 
(iv) Release to water. Requirements as 
specified in § 721.90(a)(1), (b)(1), and (c)(1). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), (i), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11484 Alkanediol, polymer with 5- 
isocyanato-1-(isocyanatomethyl)-1,3,3- trimethylcyclohexane, alkylaminoalkyl 
methacrylate-, and dialkylheteromonocycle- blocked (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as alkanediol, polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3- trimethylcyclohexane, alkylaminoalkyl methacrylate-, and dialkylheteromonocycle-blocked (PMN P–18–237) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. It is a significant 
new use to manufacture, process, or use the PMN substance in any manner or method that generates dust, spray, vapor, mist, or aerosol. 
(ii) Releases to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N = 1. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), (i), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00068 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26437 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
§ 721.11485 Alkanediol, polymer with 5- 
isocyanato-1-(isocyanatomethyl)-1,3,3- trimethylcyclohexane, alkylaminoalkyl methacrylate-blocked (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as alkanediol, polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3- trimethylcyclohexane, alkylaminoalkyl methacrylate-blocked (PMN P–18–292) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. It is a significant 
new use to manufacture, process, or use the PMN substance in any manner or method that generates dust, spray, vapor, mist, or aerosol. 
(ii) Releases to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N = 1. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), (i), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
§ 721.11486 Synthetic oil from tires 
(generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as synthetic oil from tires (PMN P–18–287) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) and (o). 
(ii) Disposal. Requirements as 
specified in § 721.85(a)(1), (b)(1), and (c)(1). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), (i) and (j) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this 
section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 
§ 721.11487 1,3-Propanediamine, N1,N1- 
dimethyl-, polymers with alkylene glycol ether with alkyltriol (3:1) mixed acrylates and adipates, and alkylene glycol monoacrylate ether with alkyltriol (3:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as 1,3-propanediamine, N1,N1-dimethyl-, polymers with alkylene glycol ether with alkyltriol (3:1) mixed acrylates and adipates, and alkylene glycol monoacrylate ether with alkyltriol (3:1) (PMN P–19–51) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the PMN substance after they have been completely reacted (cured). 
(2) The significant new uses are: 
(i) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (e) (concentration set at 0.1%), (f), (g)(1)(i), (iv) ((eye irritation), (skin sensitization), (respiratory sensitization)), (2)(i) through (v), (3)(i) and (ii), (4)(i) and (ii), and (5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(ii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f) and (k). 
(iii) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N = 3. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph. 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (d), (f) through (i), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. § 721.11488 1,3-Propanediol, 2-ethyl-2- 
(hydroxymethyl)-, polymer with oxirane, 4- (dimethylamino)benzoate. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as 1,3-propanediol, 2-ethyl-2- (hydroxymethyl)-, polymer with oxirane, 4-(dimethylamino)benzoate (PMN P–19–55, CAS No. 2067275–86–7) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) if this section. The requirements of this section do not apply to quantities of the PMN substance after they have been completely reacted (cured). 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k)(photo initiator within UV curable coating/ink formulations). It is a significant new use to manufacture, process, or use the PMN substance in any manner that results in inhalation exposure. 
(ii) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N = 12. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), (i), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain modification requirements. The provisions of § 1721.185 apply to this section. 
§ 721.11489 Titanium (4+) hydroxyl- 
alkylcarboxylate salt complex (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as titanium (4+) hydroxyl- alkylcarboxylate salt complex (PMN P– 19–159) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted (cured). 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. It is a significant 
new use to manufacture, process, or use the PMN substance in any manner or method that generates inhalation exposure. 
(ii) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N = 1. 
(b) Specific requirements. The 
provision of subpart A of this part apply 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00069 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS26438 Federal Register / Vol. 85, No. 86 / Monday, May 4, 2020 / Proposed Rules 
to this section except as modified by 
this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c), (i), and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
[FR Doc. 2020–08714 Filed 5–1–20; 8:45 am] 
BILLING CODE 6560–50–P 
DEPARTMENT OF HEALTH AND HUMAN SERVICES 
Centers for Medicare & Medicaid 
Services 
42 CFR Chapter IV 
[CMS–2324–N] 
Coordinating Care From Out-of-State 
Providers for Medicaid-Eligible Children With Medically Complex Conditions; Reopening of Comment Period 
AGENCY : Centers for Medicare & 
Medicaid Services (CMS), HHS. 
ACTION : Notice; reopening of comment 
period. 
SUMMARY : This document reopens the 
comment period for the January 21, 2020 request for information entitled ‘‘Coordinating Care From Out-of-State Providers for Medicaid-Eligible Children With Medically Complex Conditions’’. That document requested information (RFI) to seek public comments regarding the coordination of care from out-of-state providers for Medicaid-eligible children with medically complex conditions. We wish to identify best practices for using out- of-state providers to provide care to children with medically complex conditions; determine how care is coordinated for such children when that care is provided by out-of-state providers, including when care is provided in emergency and nonemergency situations; reduce barriers that prevent such children from receiving care from out-of-state providers in a timely fashion; and identify processes for screening and enrolling out-of-state providers in Medicaid, including efforts to streamline such processes for out-of- state providers or to reduce the burden of such processes on them. We intend to use the information received in response to the RFI to issue guidance to state Medicaid directors on the coordination of care from out-of-state 
providers for children with medically complex conditions. The comment period for the RFI, which ended on March 23, 2020, is reopened for 30 days from the date of publication of this notice. 
DATES : The comment period for the RFI 
published on January 21, 2020, at 85 FR 3330, is reopened. Comments will be accepted until 5 p.m., eastern daylight time, on June 3, 2020. 
ADDRESSES : You may submit comments 
as outlined in the January 21, 2020 RFI (85 FR 3330). Please choose only one method listed. 
FOR FURTHER INFORMATION CONTACT : 
Nicole Gillette-Payne, (212) 616–2465. 
SUPPLEMENTARY INFORMATION : In the 
‘‘Coordinating Care From Out-of-State Providers for Medicaid-Eligible Children With Medically Complex Conditions’’ request for information (referred to in this document as the RFI) that appeared in the January 21, 2020 Federal Register (85 FR 3330), CMS requested public comments regarding the coordination of care from out-of- state providers for Medicaid-eligible children with medically complex conditions. We wish to identify best practices for using out of-state providers to provide care to children with medically complex conditions; determine how care is coordinated for such children when that care is provided by out-of-state providers, including when care is provided in emergency and nonemergency situations; reduce barriers that prevent such children from receiving care from out-of-state providers in a timely fashion; and identify processes for screening and enrolling out-of-state providers in Medicaid, including efforts 
to streamline such processes for out-of- state providers or to reduce the burden of such processes on them. 
Since the issuance of the RFI, the 
COVID–19 global pandemic has affected many businesses and individuals and impacted healthcare systems. Responding to the public health emergency has been a priority for many of the stakeholders whose input we value. In addition, some stakeholders have reached out to request additional time to consider their recommendations related to this RFI. To maximize the opportunity for the public to provide meaningful input to CMS on the various topics raised in the RFI, we believe that it is important to allow additional time for the public to prepare comments on the RFI. We believe that reopening the public comment period in this instance would further our overall objective to obtain public input. Therefore, we are reopening the comment period for the RFI for an additional 30 days from the date of publication of this notice. 
The Administrator of the Centers for 
Medicare & Medicaid Services (CMS), Seema Verma, having reviewed and approved this document, authorizes Evell J. Barco Holland, who is the Federal Register Liaison, to electronically sign this document for purposes of publication in the Federal Register. 
Dated: April 28, 2020. 
Evell J. Barco Holland, 
Federal Register Liaison, Department of 
Health and Human Services. 
[FR Doc. 2020–09392 Filed 5–1–20; 8:45 am] 
BILLING CODE 4120–01–P 
FEDERAL COMMUNICATIONS 
COMMISSION 
47 CFR Parts 1, 2, 18 
[ET Docket No. 19–226; FCC 19–126; FRS 
16618] 
Human Exposure to Radiofrequency 
Electromagnetic Fields; Correction 
AGENCY : Federal Communications 
Commission. 
ACTION : Proposed rule; correction. 
SUMMARY : The Federal Communications 
Commission (Commission) is correcting a date that appeared in the Federal Register on April 6, 2020. In this 
document, the Commission seeks comment on expanding the range of frequencies for which its radiofrequency (RF) exposure limits apply; on applying localized exposure limits above 6 GHz in parallel to the localized exposure limits already established below 6 GHz; on specifying the conditions and methods for averaging the RF exposure, in both time and area, during evaluation for compliance with the RF exposure limits in the rules; on addressing new RF exposure issues raised by wireless power transfer (WPT) devices; and on the definition of a WPT device. 
DATES : Comments are due on or before 
June 3, 2020, and reply comments are due on or before July 6, 2020. 
ADDRESSES : Interested parties may 
submit comments and replies, identified by ET Docket No. 19–226, by any of the following methods: 
•Electronic Filers: Comments may be 
filed electronically using the internet by accessing the ECFS: http://apps.fcc.gov/ ecfs/. 
•Paper Filers: Parties who choose to 
file by paper must file an original and one copy of each filing. 
VerDate Sep<11>2014 17:15 May 01, 2020 Jkt 250001 PO 00000 Frm 00070 Fmt 4702 Sfmt 4702 E:\FR\FM\04MYP1.SGM 04MYP1jbell on DSKJLSW7X2PROD with PROPOSALS